This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Columbia Banking (COLB) upgraded to Overweight from Neutral at Piper Sandler; tgt $32
> Dr. Reddy’s (RDY) upgraded to Buy from Neutral at BofA Securities
> SAP SE (SAP) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $143
Downgrades:
> Bath & Body Works (BBWI) downgraded to Hold from Buy at Argus
> First Republic Bank (FRC) downgraded to Neutral from Overweight at Argus
> Konami Holdings (KNMCY) downgraded to Underperform from Buy at CLSA
> Sage plc (SGPYY) downgraded to Neutral from Outperform at Exane BNP Paribas
> Xero (XROLF) downgraded to Outperform from Buy at CLSA
Others:
> Autolus Therapeutics (AUTL) initiated with a Buy at Bryan Garnier; tgt $5
> Cellectis (CLLS) initiated with a Buy at Bryan Garnier; tgt $6
> CRISPR Therapeutics (CRSP) initiated with a Buy at Bryan Garnier; tgt $70
> FactSet (FDS) initiated with an Outperform at CICC; tgt $500